Johnson & Johnson execs briefed on “phantom recall” of Motrin

E-mails show company knew about plan to have contractors buy defective painkillers instead of recalling them

Topics: Medicine,

Documents obtained by The Associated Press indicate Johnson & Johnson executives were briefed on an outside contractor’s plan to buy up defective painkillers instead of issuing a recall.

Emails sent to J&J last spring by contractor Inmar show the company was informed that the plan to purchase thousands of packets of Motrin could “draw scrutiny.”

Lawmakers began scrutinizing the J&J after a slew of product recalls, most recently involving dozens of children’s medicines.

The communication between J&J and the contractor appears to contradict testimony from a J&J executive, who told lawmakers last month that J&J was unaware of the plan to use contractors posing as customers to buy the defective products off retail shelves.

More Related Stories

Featured Slide Shows

  • Share on Twitter
  • Share on Facebook
  • 1 of 11
  • Close
  • Fullscreen
  • Thumbnails



Comment Preview

Your name will appear as username ( settings | log out )

You may use these HTML tags and attributes: <a href=""> <b> <em> <strong> <i> <blockquote>